LOG IN
Analysis
Featured Analysis
Articles by Category
Current Editions
Data Graphics
Discovery & Translation
Hot Topics
BioCentury Podcasts
Special Reports & Presentations
White Papers
BCIQ Data
BCIQ
Company Profiles
Product Profiles
Target Profiles
Financial Dashboards
Events
All Events
East-West Healthcare Reception
Bio€quity Europe
Grand Rounds — U.S.
Grand Rounds — Europe
China Healthcare Summit
East-West Biopharma Summit 2026
Bio€quity Europe 2026
Podcast: The BioCentury Show
Podcast: BioCentury This Week
Webinars
My Workspace
About BioCentury
Management
Analysts & Research Team
Scientific Advisory Board
Contact
Contact Us
Forgot Password
Request a Subscription
Sponsorship & Branding Inquiry
Media Kit
Request BioCentury's BCIQ Brochure
Customer Resource Center
Career Opportunities
Request a Trial
Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a company name.
REQUEST A FREE TRIAL
Overview
Pipeline
Deals
Financings
Articles
Grupo Ferrer Internacional S.A.
Headquarters:
Barcelona, Spain
Website:
https://ferrer.com/
Year Founded:
1959
Status:
Private
BioCentury
|
May 10, 2018
Emerging Company Profile
Abac’s precision platform
How Abac’s pathogen-specific approach could reduce emergence of antibiotic resistance
Read More
BioCentury
|
Feb 16, 2018
Finance
Quark gets specific
Why Quark Venture backed antibiotics company Abac
Read More
BioCentury
|
Dec 28, 2017
Company News
Management tracks: Vivus, Peregrine
Read More
BioCentury
|
Sep 29, 2017
Financial News
Engage, Integra raise venture financings
Read More
BioCentury
|
Sep 28, 2017
Financial News
Venture roundup: Engage, Integra
Read More
BioCentury
|
May 19, 2017
Clinical News
Lorediplon meets in Phase II insomnia trial
Read More
BioCentury
|
Sep 12, 2016
Clinical News
Lorediplon: Completed Phase IIa enrollment
Read More
BioCentury
|
Sep 5, 2016
Clinical News
Ozenoxacin 1% regulatory update
Read More
BioCentury
|
Jul 11, 2016
Clinical News
Ozenoxacin 1% regulatory update
Read More
BioCentury
|
May 23, 2016
Company News
Alexza, Ferrer deal
Read More
Items per page:
10
1 - 10 of 91